Name | Description | Size | Catalog # | Supplier | |
---|---|---|---|---|---|
A-850002 | A-850002 inhibits mGluR1 in rat primary cerebellar granule neurons with an… | 10 mg | A-390 |
ALOMONE LABS |
More Info |
A-850002 | A-850002 inhibits mGluR1 in rat primary cerebellar granule neurons with an… | 25 mg | A-390 |
ALOMONE LABS |
More Info |
A-850002 | A-850002 inhibits mGluR1 in rat primary cerebellar granule neurons with an… | 5 mg | A-390 |
ALOMONE LABS |
More Info |
A-850002 | A-850002 inhibits mGluR1 in rat primary cerebellar granule neurons with an… | 50 mg | A-390 |
ALOMONE LABS |
More Info |
A-889425 | A-889425 blocks TRPV1 channels with an IC50 of 335 nM (rat) and 34 nM (hum… | 1 mg | A-195 |
ALOMONE LABS |
More Info |
A-889425 | A-889425 blocks TRPV1 channels with an IC50 of 335 nM (rat) and 34 nM (hum… | 10 mg | A-195 |
ALOMONE LABS |
More Info |
A-889425 | A-889425 blocks TRPV1 channels with an IC50 of 335 nM (rat) and 34 nM (hum… | 25 mg | A-195 |
ALOMONE LABS |
More Info |
A-889425 | A-889425 blocks TRPV1 channels with an IC50 of 335 nM (rat) and 34 nM (hum… | 5 mg | A-195 |
ALOMONE LABS |
More Info |
A-889425 | A-889425 blocks TRPV1 channels with an IC50 of 335 nM (rat) and 34 nM (hum… | 50 mg | A-195 |
ALOMONE LABS |
More Info |
293A | The HEK 293A cell line is an immortalized line of primary human embryonic… | 1 vial | ABI-TC1333 |
ACCEGEN BIOTECH |
More Info |
A10.7 | Derived from metastatic liver tumor (clinical stage IV). | 1 vial | ABC-TC533S |
ACCEGEN BIOTECH |
More Info |
A-172 | Organ: brain Disease: glioblastoma. | 1 vial | ABC-TC0022 |
ACCEGEN BIOTECH |
More Info |
A-204 | Human Muscle Rhabdomyosarcoma cell line. The A-204 cell line was establish… | 1 vial | ABC-TC445S |
ACCEGEN BIOTECH |
More Info |
A2058 | Malignant melanoma, metastasis to lymph node. | 1 vial | ABC-TC0023 |
ACCEGEN BIOTECH |
More Info |
A-253 | The A253 line is one of thirteen to be isolated and partially characterize… | 1 vial | ABC-TC0024 |
ACCEGEN BIOTECH |
More Info |
A375 | This line was derived from a 54 year old female with malignant melanoma. | 1 vial | ABC-TC0026 |
ACCEGEN BIOTECH |
More Info |
A-427 | A-427 cell line was established from the lung carcinoma of a 52-year-old C… | 1 vial | ABC-TC1339 |
ACCEGEN BIOTECH |
More Info |
A-431 | The epidermoid carcinoma cell line A-431, derived from an 85-year-old fema… | 1 vial | ABC-TC0030 |
ACCEGEN BIOTECH |
More Info |
A-498 | Established from the kidney carcinoma of a 52-year-old man in 1973. | 1 vial | ABC-TC0031 |
ACCEGEN BIOTECH |
More Info |
A549 | A549 cell line was initiated in 1972 by D.J. Giard, et al. Through explant… | 1 vial | ABC-TC0032 |
ACCEGEN BIOTECH |
More Info |
A6 | Frog (Xenopus laevis) cell line derived from kidney. Lifespan: infinite. | 1 vial | ABC-TC020S |
ACCEGEN BIOTECH |
More Info |
A-673 | Tissue: muscle Disease: rhabdomyosarcoma. | 1 vial | ABC-TC0034 |
ACCEGEN BIOTECH |
More Info |
A-704 | Human kidney adenocarcinoma. Derived from 78-year-old male. Does not produ… | 1 vial | ABC-TC0021 |
ACCEGEN BIOTECH |
More Info |
A-72 | Canine Golden Retriever tumour. Derived from tumour of thigh (unknown hist… | 1 vial | ABC-TC0036 |
ACCEGEN BIOTECH |
More Info |
A9 | Mouse C3H / An areolar and adipose tissue. Derivative of L929 selected in… | 1 vial | ABC-TC0037 |
ACCEGEN BIOTECH |
More Info |
10074-A4 | An inhibitor of the protein-protein interaction between c-Myc and Max; inh… | 1 mg | 37486-1 |
CAYMAN CHEMICAL COMPANY |
More Info |
10074-A4 | An inhibitor of the protein-protein interaction between c-Myc and Max; inh… | 10 mg | 37486-10 |
CAYMAN CHEMICAL COMPANY |
More Info |
10074-A4 | An inhibitor of the protein-protein interaction between c-Myc and Max; inh… | 25 mg | 37486-25 |
CAYMAN CHEMICAL COMPANY |
More Info |
10074-A4 | An inhibitor of the protein-protein interaction between c-Myc and Max; inh… | 5 mg | 37486-5 |
CAYMAN CHEMICAL COMPANY |
More Info |
852A | A TLR7 agonist; selectively induces NF-κB signaling in HEK293 cells… | 1 mg | 39512-1 |
CAYMAN CHEMICAL COMPANY |
More Info |
852A | A TLR7 agonist; selectively induces NF-κB signaling in HEK293 cells… | 10 mg | 39512-10 |
CAYMAN CHEMICAL COMPANY |
More Info |
852A | A TLR7 agonist; selectively induces NF-κB signaling in HEK293 cells… | 25 mg | 39512-25 |
CAYMAN CHEMICAL COMPANY |
More Info |
852A | A TLR7 agonist; selectively induces NF-κB signaling in HEK293 cells… | 5 mg | 39512-5 |
CAYMAN CHEMICAL COMPANY |
More Info |
A 83-01 | An inhibitor of ALK5, ALK4, and ALK7 (IC50s = 12, 45, and 7.5 nM, respecti… | 1 mg | 9001799-1 |
CAYMAN CHEMICAL COMPANY |
More Info |
A 83-01 | An inhibitor of ALK5, ALK4, and ALK7 (IC50s = 12, 45, and 7.5 nM, respecti… | 10 mg | 9001799-10 |
CAYMAN CHEMICAL COMPANY |
More Info |
A 83-01 | An inhibitor of ALK5, ALK4, and ALK7 (IC50s = 12, 45, and 7.5 nM, respecti… | 25 mg | 9001799-25 |
CAYMAN CHEMICAL COMPANY |
More Info |
A 83-01 | An inhibitor of ALK5, ALK4, and ALK7 (IC50s = 12, 45, and 7.5 nM, respecti… | 5 mg | 9001799-5 |
CAYMAN CHEMICAL COMPANY |
More Info |
A01 | A Smurf1 inhibitor (Kd = 3.67 nM); inhibits Smurf1-mediated ubiquitination… | 10 mg | 26137-10 |
CAYMAN CHEMICAL COMPANY |
More Info |
A01 | A Smurf1 inhibitor (Kd = 3.67 nM); inhibits Smurf1-mediated ubiquitination… | 25 mg | 26137-25 |
CAYMAN CHEMICAL COMPANY |
More Info |
A01 | A Smurf1 inhibitor (Kd = 3.67 nM); inhibits Smurf1-mediated ubiquitination… | 5 mg | 26137-5 |
CAYMAN CHEMICAL COMPANY |
More Info |
A01 | A Smurf1 inhibitor (Kd = 3.67 nM); inhibits Smurf1-mediated ubiquitination… | 50 mg | 26137-50 |
CAYMAN CHEMICAL COMPANY |
More Info |
A011 | An inhibitor of ATM kinase (IC50 = 1 nM); selective for ATM over a panel o… | 1 mg | 39183-1 |
CAYMAN CHEMICAL COMPANY |
More Info |
A011 | An inhibitor of ATM kinase (IC50 = 1 nM); selective for ATM over a panel o… | 5 mg | 39183-5 |
CAYMAN CHEMICAL COMPANY |
More Info |
A-1070722 | A GSK3β inhibitor (IC50 = <100 nM) | 1 mg | 29783-1 |
CAYMAN CHEMICAL COMPANY |
More Info |
A-1070722 | A GSK3β inhibitor (IC50 = <100 nM) | 10 mg | 29783-10 |
CAYMAN CHEMICAL COMPANY |
More Info |
A-1070722 | A GSK3β inhibitor (IC50 = <100 nM) | 25 mg | 29783-25 |
CAYMAN CHEMICAL COMPANY |
More Info |
A-1070722 | A GSK3β inhibitor (IC50 = <100 nM) | 5 mg | 29783-5 |
CAYMAN CHEMICAL COMPANY |
More Info |
A-1120 | An RBP4 antagonist (Ki = 8.3 nM for disruption of RBP4 binding to transthy… | 10 mg | 30921-10 |
CAYMAN CHEMICAL COMPANY |
More Info |
A-1120 | An RBP4 antagonist (Ki = 8.3 nM for disruption of RBP4 binding to transthy… | 5 mg | 30921-5 |
CAYMAN CHEMICAL COMPANY |
More Info |
A-1155463 | A Bcl-xL inhibitor (Ki = is = 80 and 16 nM, respectively); inhibits the gr… | 1 mg | 27369-1 |
CAYMAN CHEMICAL COMPANY |
More Info |
A-1155463 | A Bcl-xL inhibitor (Ki = is = 80 and 16 nM, respectively); inhibits the gr… | 10 mg | 27369-10 |
CAYMAN CHEMICAL COMPANY |
More Info |
A-1155463 | A Bcl-xL inhibitor (Ki = is = 80 and 16 nM, respectively); inhibits the gr… | 25 mg | 27369-25 |
CAYMAN CHEMICAL COMPANY |
More Info |
A-1155463 | A Bcl-xL inhibitor (Ki = is = 80 and 16 nM, respectively); inhibits the gr… | 5 mg | 27369-5 |
CAYMAN CHEMICAL COMPANY |
More Info |
A-1210477 | A selective Mcl-1 inhibitor (Ki = 0.43 nM; IC50 = 26.2 nM); disrupts the i… | 1 mg | 21113-1 |
CAYMAN CHEMICAL COMPANY |
More Info |
A-1210477 | A selective Mcl-1 inhibitor (Ki = 0.43 nM; IC50 = 26.2 nM); disrupts the i… | 10 mg | 21113-10 |
CAYMAN CHEMICAL COMPANY |
More Info |
A-1210477 | A selective Mcl-1 inhibitor (Ki = 0.43 nM; IC50 = 26.2 nM); disrupts the i… | 25 mg | 21113-25 |
CAYMAN CHEMICAL COMPANY |
More Info |
A-1210477 | A selective Mcl-1 inhibitor (Ki = 0.43 nM; IC50 = 26.2 nM); disrupts the i… | 5 mg | 21113-5 |
CAYMAN CHEMICAL COMPANY |
More Info |
A-1331852 | An orally bioavailable Bcl-xL inhibitor; selectively binds Bcl-xL over Bcl… | 1 mg | 22963-1 |
CAYMAN CHEMICAL COMPANY |
More Info |
A-1331852 | An orally bioavailable Bcl-xL inhibitor; selectively binds Bcl-xL over Bcl… | 10 mg | 22963-10 |
CAYMAN CHEMICAL COMPANY |
More Info |
A-1331852 | An orally bioavailable Bcl-xL inhibitor; selectively binds Bcl-xL over Bcl… | 5 mg | 22963-5 |
CAYMAN CHEMICAL COMPANY |
More Info |
A-196 | A selective inhibitor of SUV420H1 and SUV420H2 (IC50s = 25 and 144 nM, res… | 1 mg | 18317-1 |
CAYMAN CHEMICAL COMPANY |
More Info |
A-196 | A selective inhibitor of SUV420H1 and SUV420H2 (IC50s = 25 and 144 nM, res… | 5 mg | 18317-5 |
CAYMAN CHEMICAL COMPANY |
More Info |
A-196 | A selective inhibitor of SUV420H1 and SUV420H2 (IC50s = 25 and 144 nM, res… | 500 µg | 18317-500 |
CAYMAN CHEMICAL COMPANY |
More Info |
A-205804 | A potent inhibitor of E-selectin and ICAM-1 expression in HUVECs stimulate… | 1 mg | 21252-1 |
CAYMAN CHEMICAL COMPANY |
More Info |
A-205804 | A potent inhibitor of E-selectin and ICAM-1 expression in HUVECs stimulate… | 10 mg | 21252-10 |
CAYMAN CHEMICAL COMPANY |
More Info |
A-205804 | A potent inhibitor of E-selectin and ICAM-1 expression in HUVECs stimulate… | 5 mg | 21252-5 |
CAYMAN CHEMICAL COMPANY |
More Info |
A-205804 | A potent inhibitor of E-selectin and ICAM-1 expression in HUVECs stimulate… | 50 mg | 21252-50 |
CAYMAN CHEMICAL COMPANY |
More Info |
A23187 | A calcium ionophore and a microbial metabolite; induces calcium overload a… | 1 mg | 11016-1 |
CAYMAN CHEMICAL COMPANY |
More Info |
A23187 | A calcium ionophore and a microbial metabolite; induces calcium overload a… | 10 mg | 11016-10 |
CAYMAN CHEMICAL COMPANY |
More Info |
A23187 | A calcium ionophore and a microbial metabolite; induces calcium overload a… | 25 mg | 11016-25 |
CAYMAN CHEMICAL COMPANY |
More Info |
A23187 | A calcium ionophore and a microbial metabolite; induces calcium overload a… | 5 mg | 11016-5 |
CAYMAN CHEMICAL COMPANY |
More Info |
A286982 | An inhibitor that blocks the integrin-ligand interaction between LFA-1 and… | 10 mg | 27646-10 |
CAYMAN CHEMICAL COMPANY |
More Info |
A286982 | An inhibitor that blocks the integrin-ligand interaction between LFA-1 and… | 25 mg | 27646-25 |
CAYMAN CHEMICAL COMPANY |
More Info |
A286982 | An inhibitor that blocks the integrin-ligand interaction between LFA-1 and… | 5 mg | 27646-5 |
CAYMAN CHEMICAL COMPANY |
More Info |
A286982 | An inhibitor that blocks the integrin-ligand interaction between LFA-1 and… | 50 mg | 27646-50 |
CAYMAN CHEMICAL COMPANY |
More Info |
A-317491 | A P2X3 and P2X2 / 3 receptor antagonist (Kis = 22-92 nM in a calcium influ… | 1 mg | 19256-1 |
CAYMAN CHEMICAL COMPANY |
More Info |
A-317491 | A P2X3 and P2X2 / 3 receptor antagonist (Kis = 22-92 nM in a calcium influ… | 10 mg | 19256-10 |
CAYMAN CHEMICAL COMPANY |
More Info |
A-317491 | A P2X3 and P2X2 / 3 receptor antagonist (Kis = 22-92 nM in a calcium influ… | 25 mg | 19256-25 |
CAYMAN CHEMICAL COMPANY |
More Info |
A-317491 | A P2X3 and P2X2 / 3 receptor antagonist (Kis = 22-92 nM in a calcium influ… | 5 mg | 19256-5 |
CAYMAN CHEMICAL COMPANY |
More Info |
A-366 | A potent, peptide-competitive inhibitor of the lysine methyltransferase G9… | 10 mg | 16081-10 |
CAYMAN CHEMICAL COMPANY |
More Info |
A-366 | A potent, peptide-competitive inhibitor of the lysine methyltransferase G9… | 5 mg | 16081-5 |
CAYMAN CHEMICAL COMPANY |
More Info |
A-366 | A potent, peptide-competitive inhibitor of the lysine methyltransferase G9… | 50 mg | 16081-50 |
CAYMAN CHEMICAL COMPANY |
More Info |
A-419259 | An inhibitor of Src family kinases, including Src, LCK, Lyn, and Hck (IC50… | 1 mg | 25605-1 |
CAYMAN CHEMICAL COMPANY |
More Info |
A-419259 | An inhibitor of Src family kinases, including Src, LCK, Lyn, and Hck (IC50… | 10 mg | 25605-10 |
CAYMAN CHEMICAL COMPANY |
More Info |
A-419259 | An inhibitor of Src family kinases, including Src, LCK, Lyn, and Hck (IC50… | 5 mg | 25605-5 |
CAYMAN CHEMICAL COMPANY |
More Info |
A-443654 | A pan Akt inhibitor (Ki = 160 pmol / L for all three isoforms) that interf… | 1 mg | 16499-1 |
CAYMAN CHEMICAL COMPANY |
More Info |
A-443654 | A pan Akt inhibitor (Ki = 160 pmol / L for all three isoforms) that interf… | 5 mg | 16499-5 |
CAYMAN CHEMICAL COMPANY |
More Info |
A-443654 | A pan Akt inhibitor (Ki = 160 pmol / L for all three isoforms) that interf… | 500 µg | 16499-500 |
CAYMAN CHEMICAL COMPANY |
More Info |
A-484954 | An eEF-2K inhibitor; reduces eEF-2K autophosphorylation in various cancer… | 1 mg | 28279-1 |
CAYMAN CHEMICAL COMPANY |
More Info |
A-484954 | An eEF-2K inhibitor; reduces eEF-2K autophosphorylation in various cancer… | 10 mg | 28279-10 |
CAYMAN CHEMICAL COMPANY |
More Info |
A-484954 | An eEF-2K inhibitor; reduces eEF-2K autophosphorylation in various cancer… | 25 mg | 28279-25 |
CAYMAN CHEMICAL COMPANY |
More Info |
A-484954 | An eEF-2K inhibitor; reduces eEF-2K autophosphorylation in various cancer… | 5 mg | 28279-5 |
CAYMAN CHEMICAL COMPANY |
More Info |
A-485 | A p300 / CBP inhibitor (IC50 = 60 nM); decreases H3K27Ac levels in PC3 cel… | 1 mg | 24119-1 |
CAYMAN CHEMICAL COMPANY |
More Info |
A-485 | A p300 / CBP inhibitor (IC50 = 60 nM); decreases H3K27Ac levels in PC3 cel… | 10 mg | 24119-10 |
CAYMAN CHEMICAL COMPANY |
More Info |
A-485 | A p300 / CBP inhibitor (IC50 = 60 nM); decreases H3K27Ac levels in PC3 cel… | 25 mg | 24119-25 |
CAYMAN CHEMICAL COMPANY |
More Info |
A-485 | A p300 / CBP inhibitor (IC50 = 60 nM); decreases H3K27Ac levels in PC3 cel… | 5 mg | 24119-5 |
CAYMAN CHEMICAL COMPANY |
More Info |
A-61603 | A selective α1A-adrenergic receptor agonist that is at least 35-fold… | 1 mg | 17358-1 |
CAYMAN CHEMICAL COMPANY |
More Info |
A-61603 | A selective α1A-adrenergic receptor agonist that is at least 35-fold… | 10 mg | 17358-10 |
CAYMAN CHEMICAL COMPANY |
More Info |
A-61603 | A selective α1A-adrenergic receptor agonist that is at least 35-fold… | 5 mg | 17358-5 |
CAYMAN CHEMICAL COMPANY |
More Info |
A-66 | A potent, selective inhibitor of the PI3K isoform p110α (IC50 = 32 n… | 1 mg | 17382-1 |
CAYMAN CHEMICAL COMPANY |
More Info |